NCT04522596View on ClinicalTrials.gov

Effect of Dual Bronchodilation With Umeclidinium/Vilanterol on Patients With COPD, Hyperinflation and Heart Failure

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 21, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
CopdHeart Failure
Interventions
DRUG

Umeclidinium/vilanterol

Umeclidinium/vilanterol 55/22 μg inhaled once a day

OTHER

Placebo

Placebo inhaled once a day

Trial Locations (1)

28007

RECRUITING

Hospital General Universitario Gregorio Marañón, Madrid

All Listed Sponsors
lead

Luis Puente Maestu

OTHER